<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02438306</url>
  </required_header>
  <id_info>
    <org_study_id>BC-14-001</org_study_id>
    <nct_id>NCT02438306</nct_id>
  </id_info>
  <brief_title>CardiAMP™ Heart Failure Trial</brief_title>
  <official_title>Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Post Myocardial Infarction Heart Failure (CardiAMP Heart Failure Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioCardia, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BioCardia, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center, randomized (3 Treatment : 2 Sham Control),
      sham-controlled, patient- and evaluator-blinded study comparing treatment with the CardiAMP
      cell therapy to a sham treatment. A roll-in phase with a maximum of 10 subjects may occur.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure is a clinical condition in which the output of blood from the heart is
      insufficient to meet the metabolic demands of the body. In 2015, the American Heart
      Association, or AHA, report on heart disease statistics estimated that there are 5.7 million
      Americans over the age of 20 that have heart failure. Heart failure is increasingly prevalent
      due to the aging population and the increase in major cardiovascular risk factors, including
      obesity and diabetes.

      The AHA also estimates that one in five adults will develop heart failure after the age of
      40. During heart failure progression, the heart steadily loses its ability to respond to
      increased metabolic demand, and mild exercise soon exceeds the heart's ability to maintain
      adequate output. Towards the end stage of the disease, the heart cannot pump enough blood to
      meet the body's needs at rest. At this stage, fluids accumulate in the extremities or in the
      lungs making the patient bedridden and unable to perform the activities of daily living. The
      long-term prognosis associated with heart failure is approximately 50% mortality at five
      years following the initial diagnosis.

      CardiAMP is a comprehensive therapeutic treatment that comprises (i) a point of care cell
      processing platform, and (ii) a biotherapeutic delivery system. CardiAMP is the first
      comprehensive therapeutic treatment utilizing a patient's own cells for the treatment of
      ischemic systolic heart failure, which is heart failure that develops after a heart attack.
      In the screening process, the physician extracts a small sample of the patient's bone marrow
      in an outpatient procedure performed under local anesthesia. The clinic sends the sample to a
      centralized diagnostic lab, which tests the sample. During the treatment, a clinician
      harvests and then prepares the patient's own bone marrow mononuclear cells, or autologous
      cells, using the CardiAMP point of care cell processing platform, which a cardiologist then
      delivers into the heart using the Helix biotherapeutic delivery system.

      BioCardia intends to submit data obtained from this clinical trial in a Pre-Market Approval
      Application to the United States Food and Drug Administration
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Six (6) Minute Walk Distance</measure>
    <time_frame>12 Months</time_frame>
    <description>Mean change in Six (6) Minute Walk Distance at 12 months compared to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival Rate</measure>
    <time_frame>12 Months</time_frame>
    <description>Survival rate compared between both study arms (non-inferiority, treatment vs sham)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events (MACE)</measure>
    <time_frame>12 months</time_frame>
    <description>Freedom from MACE, defined as the composite of all-cause death, hospitalization for worsening heart failure, nonfatal recurrent myocardial infarction, placement of a left ventricular assist device (LVAD), or heart transplantation (non-inferiority, treatment vs sham)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure Questionnaire (MLHFQ)</measure>
    <time_frame>12 months</time_frame>
    <description>Mean change in quality of life score as measured by the MLHFQ at 12 months compared to baseline (superiority, treatment vs sham)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first MACE</measure>
    <time_frame>12 months</time_frame>
    <description>Time (in days) to first MACE during the 12 months after the baseline measurements (superiority, treatment vs sham)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival rate</measure>
    <time_frame>12 months</time_frame>
    <description>Survival rate compared between both study arms (superiority, treatment vs sham)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CardiAMP cell therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placement of an introducer guidewire, performance of a left ventriculogram, and treatment with autologous cell therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Comparator</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Placement of an introducer guidewire and performance of a left ventriculogram with no autologous cell therapy treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous cell therapy</intervention_name>
    <description>Autologous cell therapy delivered into the heart muscle using the CardiAMP Cell Therapy System. The CardiAMP Cell Therapy System consists of the CardiAMP Cell Separator, a cardiac delivery catheter, and flexible tip guide catheter.</description>
    <arm_group_label>CardiAMP cell therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>An introducer guidewire is placed into the heart and left ventriculography is performed just like it is in the Experimental Arm but no autologous cell therapy is delivered.</description>
    <arm_group_label>Sham Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New York Heart Association (NYHA) Class II or III

          -  A diagnosis of chronic ischemic left ventricular dysfunction secondary to myocardial
             infarction (MI).

          -  On stable evidence-based medical and device therapy for heart failure or
             post-infarction left ventricular dysfunction, per the 2013 ACC/AHA Heart Failure
             guidelines, for at least three (3) months prior to randomization.

          -  Left ventricular ejection fraction between 20% and 40%.

          -  Cell potency assay score of '3'.

        Exclusion Criteria:

        • Other cardiac or vascular system or other health-related criteria which may be seen in a
        patient's history and physical examination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl Pepine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amish Raval, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Duckers, MD, PhD</last_name>
    <phone>650-226-0120</phone>
    <email>info@biocardia.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Kirkland</last_name>
      <email>Kirkland.Sarah@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam Johnstone, RN</last_name>
      <phone>323-409-3319</phone>
      <email>myriam.johnstone@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Luanne Grazetter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey Early, BS</last_name>
      <email>Tracey.Early@cshs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford Medical Center, Stanford Health Care</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fouzia Khan, BS</last_name>
      <email>fouziak@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milena Ferreira</last_name>
      <email>ferreiml@sutterhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado, Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alisha Shudy</last_name>
      <email>Alisha.Shudy@ucdenver.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MedStar Health Research Institute</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shreejana Pokharel, MPH</last_name>
      <email>Shreejana.Pokharel@medstar.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morton Plant Mease Health Care</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delia Johnson, RN</last_name>
      <email>Delia.Johnson@baycare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida - College of Medicine/ div of Cardiovascular Medicine</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah J Long, RN</last_name>
      <email>Sarah.Long@medicine.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Roshevsky</last_name>
      <email>droshevs@nm.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Iowa Heart</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Murphy, RN</last_name>
      <email>MEMurphy@iowaheart.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Hopkins University School of Medicine - Dept of Cardiology</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Dudek, RN</last_name>
      <email>adudek1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Suburban Hospital</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20814</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Lowe</last_name>
      <email>slowe6@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Fox, RN</last_name>
      <email>MFOX@hfhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Melanee Schimmel, RN</last_name>
      <email>mschimm@hfhs.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Michigan Cardiovascular Institute</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Reif</last_name>
      <email>Amanda.Reif@ascension.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michigan Heart - St.Joseph Mercy Health System (Trinity Health)</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nora Marchelletta, RN</last_name>
      <email>nmarchelletta@MichiganHeart.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Atlantic Health System</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy VanZile, RN</last_name>
      <email>Catherine.VanZile@atlantichealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Jenelle Purpura, RN</last_name>
      <email>Janelle.Purpura@atlantichealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raven Dwyer</last_name>
      <email>Raven.Dwyer@nuylangone.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heather Glum</last_name>
      <email>hep2011@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jolene Durham, RN, MSN</last_name>
      <email>S.Durham@hillcrest.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Sampaio</last_name>
      <email>ssampaio@texasheart.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University (VCU) Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Cei</last_name>
      <email>laura.cei@vcuhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Health Services</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlene Boisjolie, MA, RN</last_name>
      <email>Charlene.Boisjolie@swedish.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Division of Cardiovascular Medicine, University of Wisconsin Hospital and Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cassondra Vander Ark, RN MS CCRC</last_name>
      <email>cav@medicine.wisc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.biocardia.com</url>
    <description>Website for the study sponsor</description>
  </link>
  <link>
    <url>http://www.CardiAMP.com</url>
    <description>Website with additional information for patients, family members or friends</description>
  </link>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2015</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

